Pharmacological Impacts of Mucopolysacccharide Polysulfates in the Epidermis Involves Inhibition of Amphiregulin‐Mediated Signals in Keratinocytes
Experimental Dermatology · 2024
DOI: 10.1111/exd.70000 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Dermatology, 2024. Verfasst von Ryo Hirase und 4 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Medicine, Chiba University, Chiba, Japan. Hauptthemen laut MEDLINE: Amphiregulin, Keratinocytes, Polysaccharides, Phosphates. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The epidermis, the most superficial layer of the human skin, serves a critical barrier function, protecting the body from external pathogens and allergens. Dysregulation of epidermal differentiation contributes to barrier dysfunction and has been implicated in the pathology of various dermatological diseases, including atopic dermatitis (AD). Mucopolysaccharide polysulphate (MPS) is a moisturising agent used to treat xerosis in patients with AD. However, its mechanism of action on keratinocytes, the main constituents of the epidermis, remains unclear. In this study, we investigated the effect of MPS on keratinocytes by subjecting adult human epidermal and three‐dimensional cultured keratinocytes to MPS treatment, followed by transcriptome analysis. The analysis revealed that MPS treatment enhances keratinocyte differentiation and suppresses proliferation. We focused on amphiregulin (AREG), a membrane protein that belongs to the epidermal growth factor (EGF) family and possesses a heparin‐binding domain, as a significant target among the genes altered by MPS. MPS exerted an inhibitory effect directly on AREG, rather than on EGF receptors or other members of the EGF family. Furthermore, AREG leads to a reduction in epidermal barrier function, whereas MPS contributes to barrier enhancement via AREG inhibition. Collectively, these findings suggest that MPS modulates barrier function through AREG inhibition, offering insights into potential therapeutic strategies for skin barrier restoration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate School of Medicine, Chiba University, Chiba, Japan.
- Kyoto R&D Center, Maruho Co., Ltd., Kyoto, Japan.
- RIKEN Center for Integrative Medical Sciences (IMS-RCAI), Kanagawa, Japan.
ORCID-Profile: Ryo Hirase, Tomohiro Miyai, Hiroshi Kawasaki, Haruhiko Koseki
Zitieren
APA
Hirase, R., Fujita, T., Miyai, T., Kawasaki, H., & Koseki, H. (2024). Pharmacological Impacts of Mucopolysacccharide Polysulfates in the Epidermis Involves Inhibition of Amphiregulin‐Mediated Signals in Keratinocytes. Experimental Dermatology. https://doi.org/10.1111/exd.70000
Vancouver
Hirase R, Fujita T, Miyai T, Kawasaki H, Koseki H. Pharmacological Impacts of Mucopolysacccharide Polysulfates in the Epidermis Involves Inhibition of Amphiregulin‐Mediated Signals in Keratinocytes. Experimental Dermatology. 2024. doi:10.1111/exd.70000
BibTeX
@article{Hirase2024,
author = {Hirase, Ryo and Fujita, Tomoyuki and Miyai, Tomohiro and Kawasaki, Hiroshi and Koseki, Haruhiko},
title = {Pharmacological Impacts of Mucopolysacccharide Polysulfates in the Epidermis Involves Inhibition of Amphiregulin‐Mediated Signals in Keratinocytes},
journal = {Experimental Dermatology},
year = {2024},
doi = {10.1111/exd.70000}
}
EUVIMED